Evidence map›Paper›PMID 35892756›Full record

ArticleBioengineering (Basel, Switzerland)2022

A Fusion Biopsy Framework for Prostate Cancer Based on Deformable Superellipses and nnU-Net.

Nicola Altini, Antonio Brunetti, Valeria Pia Napoletano, Francesca Girardi, Emanuela Allegretti, Sardar Mehboob Hussain, Gioacchino Brunetti, Vito Triggiani, Vitoantonio Bevilacqua, Domenico Buongiorno

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nicola AltiniDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.ORCID 0000-0001-7353-4968
Antonio BrunettiDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.ORCID 0000-0002-1934-0983
Valeria Pia NapoletanoDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.
Francesca GirardiDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.
Emanuela AllegrettiDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.ORCID 0000-0002-3265-0935
Sardar Mehboob HussainDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.ORCID 0000-0003-2084-9880
Gioacchino BrunettiMasmec Biomed SpA, Via delle Violette n.14, 70026 Modugno, BA, Italy.
Vito TriggianiMasmec Biomed SpA, Via delle Violette n.14, 70026 Modugno, BA, Italy.
Vitoantonio BevilacquaDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.ORCID 0000-0002-3088-0788
Domenico BuongiornoDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, 70126 Bari, BA, Italy.ORCID 0000-0002-2024-5369
Polytechnic University of Bari · ITMasmec (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In prostate cancer, fusion biopsy, which couples magnetic resonance imaging (MRI) with transrectal ultrasound (TRUS), poses the basis for targeted biopsy by allowing the comparison of information coming from both imaging modalities at the same time. Compared with the standard clinical procedure, it provides a less invasive option for the patients and increases the likelihood of sampling cancerous tissue regions for the subsequent pathology analyses. As a prerequisite to image fusion, segmentation must be achieved from both MRI and TRUS domains. The automatic contour delineation of the prostate gland from TRUS images is a challenging task due to several factors including unclear boundaries, speckle noise, and the variety of prostate anatomical shapes. Automatic methodologies, such as those based on deep learning, require a huge quantity of training data to achieve satisfactory results. In this paper, the authors propose a novel optimization formulation to find the best superellipse, a deformable model that can accurately represent the prostate shape. The advantage of the proposed approach is that it does not require extensive annotations, and can be used independently of the specific transducer employed during prostate biopsies. Moreover, in order to show the clinical applicability of the method, this study also presents a module for the automatic segmentation of the prostate gland from MRI, exploiting the nnU-Net framework. Lastly, segmented contours from both imaging domains are fused with a customized registration algorithm in order to create a tool that can help the physician to perform a targeted prostate biopsy by interacting with the graphical user interface.

Indexed as

deformable superellipsesMRI-targeted biopsyprostate segmentationTRUS

Identifiers

PMID35892756
PMCPMC9394419
OpenAlexW4288039445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.